Skip to main content
. 2016 May 25;3:30. doi: 10.3389/fsurg.2016.00030

Table 2.

Examples of metastatic events, their molecular processes, and potential targeted chemotherapeutics.

Cellular event Pathway(s) implicated Potential personalized treatments
Migration across BBB cathepsin S Inhibitors in development
miR-181C None to date
miR-105 None to date
Survival in CNS microenvironment mTOR Everolimus, temsirolimus
CDK Palbociclib, others in development
VEGF Bevacizumab
EGFR Erlotinib
Establishment of radioresistance Chk1 Inhibitors in development
c-Met Cabozantinib